Zhejiang Hisun Pharmaceutical (600267.SH): Finasteride API approved for listing.

15:47 11/06/2026

Haisco Pharmaceutical (600267.SH) announced that the company recently received the "Chemical Raw Material Pharmaceutical Market Application Approval Notice" issued by the National Medical Products Administration for the approval of nonane ketone active pharmaceutical ingredient. Nonane ketone is used for adult patients with chronic kidney disease associated with type 2 diabetes.

Zhejiang Hisun Pharmaceutical (600267.SH) announced that the company has recently received the "Notice of Approval for the Listing Application of Chemical Raw Materials" issued by the National Medical Products Administration for the raw material drug non-alanyl acetone. Non-alanyl acetone is suitable for adult patients with chronic kidney disease associated with type 2 diabetes.

MMG (01208) subsidiary awarded US$125 million revolving loan.

On June 11, Zhuzhou CRRC Times Electric (03898) spent approximately 60.37 million Hong Kong dollars to repurchase 152.18 million shares.

Shenwan Hongyuan Group (06806): "23 Shen Hong 02" will pay interest on June 15th.

MMG (01208) subsidiary awarded US$125 million revolving loan.

On June 11, Zhuzhou CRRC Times Electric (03898) spent approximately 60.37 million Hong Kong dollars to repurchase 152.18 million shares.

Shenwan Hongyuan Group (06806): "23 Shen Hong 02" will pay interest on June 15th.